{"name":"Romark Laboratories L.C.","slug":"romark-laboratories-l-c","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOUFp0QXlRN2ZmZEp6d0tEVUZUVllCeUZKUjY4bWF2WHJWZFBNQ0xudjREZldFYzlxdDNFc28wcjZXQjdteEVSRUFJdzU0TXFBcDI3NkVQNmgwS29FOF8zVkhJRThxVGVyTHp5SkdvRGt5cGdpVlNQQlU4VG5jdUlyT3dGVE1Mc2dHbnVLVWp2bnQ4eFV3OXN3RURn?oc=5","date":"2026-02-08","type":"patent","source":"lupin.com","summary":"Lupin Launches Authorized Generic Version of Alinia® - Lupin | Press Release - lupin.com","headline":"Lupin Launches Authorized Generic Version of Alinia® - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQRGRkeHR1OXhIdWxoOHp5X1FoZXpBaGVRVG04WTZQN2dNSlc5cFl1aUg0bUYwc1c0bFk0S2ZyQmtIeTVfMUJnVjJraW1rank5RVdKYjh0YVVhUHZhOXRmbl9oS0t0WWpLSW1uR2w5ampKLXhEbU9tS1BkblFjT1hiSUNjZHFCYXA4d3hSUXFSeGNkWGxZOXBCTg?oc=5","date":"2024-07-15","type":"pipeline","source":"newsismybusiness.com","summary":"Banco Popular de Puerto Rico sues Romark Global Pharma for $9.2M - newsismybusiness.com","headline":"Banco Popular de Puerto Rico sues Romark Global Pharma for $9.2M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQWEp1MWRFaHZMT3VtRm1LT0N1UFFQSks3SUVLQVh3MTVFU3hmUnZQX01WUXJDVW02dXo3SlNsZDV5TE5Xam5jT1BQOE5kYTRhMmdnUzUySFZnUTE1OTR5SmlVTVZvd2NJMGFFdHJFZURSSkVMYXVoY0Z0SzBMUmVIVHNPREhKdTB1YUVRX2pDOEZBTjBzTlltZzZMejNObW1YM0JGLTdEY9IBrAFBVV95cUxNSUQ5bmVjRGZnVm5KNUx0ekY5QTd5Y1dCM0RDM1NQRU8yV0JqTFVyVWF2MkI4MG9UNnFkWkFROXhjY2tuamRpUEVIcTFOTnRUc2VnLVFmc0hPM1FuOUFZM3duSF8yX19hRVlwNm9EQ1ZiY215MXBaVnpURmhrTk11cUV2Y25WRk8xZjlOdDZqaEkxdFQtT01vQjJqbHRXb1pNMklUYXV3Wncxbktj?oc=5","date":"2021-03-10","type":"patent","source":"Medical Dialogues","summary":"Lupin launches generic diarrhea drug Nitazoxanide - Medical Dialogues","headline":"Lupin launches generic diarrhea drug Nitazoxanide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPZUlUQ0dWX29pMXZUVkhxTUNnWXJrLWtBbWd6M2pSQm1uVUdCWUFzU0R0amdzcUN1bGE5Y2UtU0szVHRvb2lBVWtnNndoc29uSkc3Z3JaeXA2RnZhcXNTWWxJYjMyZjJYMzYzSkZTQk45UmtDTnZCR25hSFItSHRmRUhJTV8zUDk1VW1PWmxNbzltNC1lVExfeXlLZU1wSGpZTDUxS2FUOTY1WGwzdURpRU5mX19CQkM1TEwyLXN6c9IBzAFBVV95cUxOZXNwLVhzR0d0bVVlTFo0OUVtbnAwMzFUMDFKbm1tR1RHekFCa0M2X2lJcjBKVkF5ZzM0SlFKYkc4MnVPaWNqX0dzVjBtci12NE9LTFNtQUpEckowa29IRWVrb1dNbmh4OGdjTVV6RC13cVJCcnNaLUtYTDlfWV9zRGJlRWQzYnk3X1FhcEtXWFFKSVo1SmJHaVgzMlJTaXNCbk14enZMcVBZd3drSmU4Y0pDa2RpLVN6cWhFMkFDNmFBeDZ3dWZJTENublI?oc=5","date":"2013-08-07","type":"earnings","source":"Mint","summary":"Lupin's Q1 net rises 43%, signs pact with US' Romark Labs - Mint","headline":"Lupin's Q1 net rises 43%, signs pact with US' Romark Labs","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPRTlOeUNOMFJhaHJFV3lUdGFiS00yZ0lDWjdnZjJvQkJUV1JYZ08tN2dCQnh6bFdNVWlPaWVSVFZJSjlpYU9hTHAyYnJsZUVHQndJT3JCUGRzQVFkVl9NUnN4ZHRMWlo1dUxDVGpCM0ROTEM3d19NX3VOcU1HNjVHdFpDUnNUU1BNaFptUWUwX0dJc2F1MGhiZkJVcDg0anJaT2JOTjdKQjM5N0xEVG9JRWpRdGNvcmd5UTZHT1EydkMwSnpQaGlzVGZ1M0FzSmY3eUFMZm1Wbzg?oc=5","date":"2013-02-28","type":"pipeline","source":"PR Newswire","summary":"Romark Laboratories Awarded Contract For Late-Stage Development Of New Influenza Drug - PR Newswire","headline":"Romark Laboratories Awarded Contract For Late-Stage Development Of New Influenza Drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}